Jeffrey Mulhern is a Nephrology physician affiliated with Baystate Medical Center. OpenAlex indexes 54 publications with 1,399 citations (h-index 17).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
134 Capital Dr Ste E
West Springfield, MA 010891320
Telephone
413-733-0010Provider last certified this registry record 11 Jan 2022.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Bard Peripheral Vascular, Inc.Program year20251 payment
- Travere Therapeutics, Inc.Program year20251 payment
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20222 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
47.2%Calcium channel blocker9%Amlodipine Besylate74%Nifedipine Er26%Part D≥52 patientsBeta blocker7.2%Carvedilol54%Metoprolol Succinate24%Metoprolol Tartrate15%Propranolol Hcl Er7%Part D<11 patients+ 10 more classes in this area
Metabolism & gastrointestinal
19.1%SGLT2 inhibitor5.9%Farxiga61%Jardiance27%Dapagliflozin12%Part D<11 patientsProton pump inhibitor3.5%Omeprazole76%Pantoprazole Sodium24%Part D<11 patients+ 8 more classes in this area
Nervous system
16.9%Opioid Agonist8.7%Oxycodone Hcl37%Tramadol Hcl29%Hydromorphone Hcl14%Oxycontin13%Methadone Hcl6%Part D<11 patientsGabapentinoids2.6%Gabapentin67%Pregabalin33%Part D<11 patients+ 5 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Semaglutide (S) Completely Reverses the Severe Chronic Myopathy of Hyperkalemic Periodic Paralysis
Journal of the American Society of Nephrology
2024 - A New Cause of Glycyrrhizic Acid-Induced Apparent Mineralocorticoid Excess (AME) Syndrome with Hyperadrenergic Symptoms
Journal of the American Society of Nephrology
2024 - Tris(hydroxymethyl)aminomethane Reverses Tumor-Induced Lactic Acidosis
Journal of the American Society of Nephrology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Daniel Skiest, MD
Baystate Medical Center
Katie Nason, MD
Baystate Medical Center
Prarthna Bhardwaj, MD
Baystate Medical Center
Daniel Engelman, MD
Baystate Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”